SARomics Biostructures provides premium protein crystallization, protein crystallography and drug discovery services. Our strategic location in close vicinity to the new Swedish MAX-IV synchrotron in Lund provides us with instant access to beamlines, minimizing the need for crystal transportation to remote synchrotrons and allowing us to offer to our customers quick services at highly competitive prices.
Latest News & Event!
Novo Seeds and Almi Invest together invest up to 6.3 million SEK in the Lund-based
company Merozyne Therapeutics. Merozyne Therapeutics has been established to develop a treatment for MDC1A and has SARomics Biostructures and Red Glead Discovery among the founders.
More coming up:
SARomics Biostructures sponsors the Fragment-based Lead Discovery Conference 2016, Cambridge, Massachusetts, October 9th - 12th 2016.
SARomics Biostructures together with Novo Nodisk and MAXIV laboratory arrange the 24th Protein Structure Determination in Industry meeting, which will take place 13-15 November 2016 in Malmö, Sweden.
Prof Mikael Akke, Founder and Director NMR services, will give a talk with a title: “Innovative NMR methods for antibody characterization” at Analytical Characterization of Therapeutic Proteins workshop organized by the Swedish Academy of Pharmaceutical Sciences.